Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H3GI
|
||||
Former ID |
DNC008941
|
||||
Drug Name |
4-(p-Tolyl)spiro[chromene-2,4'-piperidine]
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529689] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H21NO
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=CC=CC=C42
|
||||
InChI |
1S/C20H21NO/c1-15-6-8-16(9-7-15)18-14-20(10-12-21-13-11-20)22-19-5-3-2-4-17(18)19/h2-9,14,21H,10-13H2,1H3
|
||||
InChIKey |
YDXKUUFNKUXOBE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [529689] | |
Delta-type opioid receptor | Target Info | Inhibitor | [529689] | ||
Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [529689] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.